Clinical Trial Update: A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates the Phase 1/2 study of KB-0742 in relapsed or refractory solid tumors, including platinum-resistant high-grade serous ovarian …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer
• Non-hodgkin Lymphoma

Drugs mentioned

• KB-0742

Snippet

Sponsor: Kronos Bio | Conditions: Relapsed Solid Tumors, Refractory Solid Tumors | Phase 1, Phase 2 | Status: TERMINATED